Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,623 | -8,650 | -5,942 | -3,401 | -17,192 |
| Depreciation Amortization | 240 | 187 | 128 | 64 | 265 |
| Accounts receivable | N/A | 403 | 254 | N/A | N/A |
| Other Working Capital | 1,687 | -259 | 175 | -836 | -496 |
| Other Operating Activity | 603 | 274 | 639 | 1,110 | -3,035 |
| Operating Cash Flow | $-9,093 | $-8,045 | $-4,746 | $-3,063 | $-20,458 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 2,211 |
| PPE Investments | 12 | N/A | N/A | N/A | -18 |
| Investing Cash Flow | $12 | $0 | $0 | $N/A | $2,193 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,967 | 6,909 | 6,909 | 2,539 | 18,978 |
| Financing Cash Flow | $7,967 | $6,909 | $6,909 | $2,539 | $18,978 |
| Beginning Cash Position | 1,485 | 1,485 | 1,485 | 1,485 | 772 |
| End Cash Position | 371 | 349 | 3,648 | 961 | 1,485 |
| Net Cash Flow | $-1,114 | $-1,136 | $2,163 | $-524 | $713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,093 | -8,045 | -4,746 | -3,063 | -20,458 |
| Capital Expenditure | 12 | N/A | N/A | N/A | -18 |
| Free Cash Flow | -9,081 | -8,045 | -4,746 | -3,063 | -20,476 |